Clinical Trials on Varicella Zoster Virus Infection in Sweden

Total 272 results

Region Skane

Completed

Subunit Vaccine Against Herpes Zoster in RA Patients Treated With JAK-inhibitors (VACCIMIL-ZOSTER)

Rheumatoid Arthritis | Healthy Controls

Sweden
GlaxoSmithKline

Completed

Safety and Immunogenicity of the Zoster Vaccine GSK1437173A in Elderly Subjects

Herpes Zoster

Germany, Czechia, Sweden, Netherlands
GlaxoSmithKline

Completed

Study to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2 Additional Doses at 10 Years After Initial Vaccination, in Healthy Subjects Aged 60 Years of Age(YOA) and Older

Herpes Zoster

Germany, Czechia, Sweden
GlaxoSmithKline

Completed

Study of Long Term Immune Responses and Safety of the GSK Herpes Zoster Vaccine in Healthy Subjects

Herpes Zoster

Germany, Czechia, Sweden, Netherlands
GlaxoSmithKline

Completed

Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox

Varicella | Chickenpox Vaccines

Russian Federation, Romania, Czechia, Slovakia, Italy, Sweden, Poland, Greece, Norway, Lithuania
GlaxoSmithKline

Completed

Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older

Herpes Zoster | Herpes Zoster Vaccine

United States, Australia, Spain, Finland, Germany, Japan, Taiwan, Canada, Sweden, Korea, Republic of, Czechia, Hong Kong, Mexico, Italy, Brazil, Estonia, France, United Kingdom
GlaxoSmithKline

Completed

A Study to Assess Frailty of Subjects During ZOSTER-006 and ZOSTER-022

Herpes Zoster

United States, Australia, Germany, Spain, Japan, Taiwan, Sweden, Korea, Republic of, Hong Kong, Mexico, Canada, France, Italy, Brazil, Estonia, United Kingdom, Czechia, Finland
GlaxoSmithKline

Active, not recruiting

A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults

Herpes Zoster

United States, Australia, Finland, Germany, Japan, Taiwan, Sweden, Spain, Korea, Republic of, Brazil, Mexico, Italy, Canada, Czechia, Estonia, France, Hong Kong, United Kingdom
GlaxoSmithKline

Completed

A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older Adults

Herpes Zoster

United States, Australia, Spain, Finland, Germany, Japan, Taiwan, Sweden, Korea, Republic of, Brazil, Mexico, Canada, Italy, France, Czechia, Estonia, Hong Kong, United Kingdom
GlaxoSmithKline

Completed

Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and Older

Herpes Zoster

United States, Australia, Spain, Finland, Germany, Japan, Taiwan, Canada, Sweden, Korea, Republic of, Czechia, Hong Kong, Mexico, Italy, Brazil, Estonia, France, United Kingdom
GlaxoSmithKline

Completed

Cross-vaccination Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) Studies.

Herpes Zoster

United States, Australia, Germany, Spain, Finland, Japan, Taiwan, Sweden, Korea, Republic of, Hong Kong, Mexico, Canada, Italy, France, Brazil, Estonia, United Kingdom, Czechia
GlaxoSmithKline

Completed

Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers

Herpes Zoster

France, Spain, Taiwan, Belgium, Singapore, United States, Hong Kong, Russian Federation, Finland, Korea, Republic of, Czechia, Australia, Canada, Sweden, Poland, United Kingdom, Panama, Italy, Turkey, Pakistan, New Zealand
Karolinska Institutet

Enrolling by invitation

Age Related Differences in Respiratory Immune Responses in Influenza Virus Infection (NPA-DC)

RSV Infection | SARS CoV 2 Infection | Influenza B Virus Infection | Influenza A Infection

Sweden
Dalarna County Council, Sweden

Completed

Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19

Coronaviridae Infections | Virus Diseases | Corona Virus Infection

Sweden
Vastra Gotaland Region
Detectivio AB

Completed

Covid-19 Triage Using Camera-based AI

Coronavirus Infections

Sweden
Tripep AB
Inovio Pharmaceuticals

Unknown

Phase I/IIa Dose Ranging CHRONVAC-C® Study in Chronic HCV Patients

Chronic Hepatitis C Virus Infection

Sweden
Uppsala University
Swedish University of Agricultural Sciences

Completed

Inflammatory Mediators Associated With Infection by Respiratory Syncytial Virus (IMAR)

Respiratory Tract Infections | Respiratory Syncytial Virus Infections

Sweden
Lund University
Swedish Cancer Society

Completed

Use of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical Dysplasia

Cervical Intraepithelial Neoplasia | Human Papillomavirus Infection

Sweden
Karolinska Institutet
Norwegian Institute of Public Health; Finnish Institute for Health and Welfare

Completed

Tobacco Use and the Risk of COVID-19 and Adverse Outcomes

Infections | Virus Diseases | Respiratory Tract Infections | COVID-19 | Pneumonia, Viral | Pneumonia | SARS-CoV-2 Infection

Sweden
Sahlgrenska University Hospital, Sweden

Completed

Timing of Tracheotomy in Covid-19 Patients (TTCOV19)

Covid-19 | Respiratory Insufficiency | Corona Virus Infection | ARDS | Tracheostomy Complication

Sweden
Miriam Elfström
Karolinska University Hospital

Recruiting

Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden

Cervical Cancer | HPV Infection | CIN 2/3

Sweden
Uppsala University
Center for Clinical Research Dalarna, Sweden

Completed

The Impact of Premorbid Illnesses on the Risk of ICU Admission and Short-term Outcome

Sepsis | Corona Virus Infection | ARDS, Human

Sweden
Gilead Sciences

Completed

Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination in Participants With Chronic Hepatitis C Virus Infection

Hepatitis C Virus Infection

Russian Federation, Sweden
Matti Sällberg

Completed

A Randomized, Phase I Study of DNA Vaccine OC-007 as a Booster Dose of COVID-19 Vaccine (OpenCorona1)

COVID-19 Respiratory Infection | COVID-19 Vaccine Adverse Reaction

Sweden
Karolinska Institutet
Karolinska University Hospital

Active, not recruiting

Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare With Regard to Vaccinations

SARS-CoV 2

Sweden
Karolinska University Hospital

Completed

Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare

SARS-CoV 2

Sweden
Oslo University Hospital
Karolinska University Hospital; Tine

Completed

The Effect of Probiotics in HIV-1 Infection (ProGut)

HIV-1 Infection

Norway, Sweden
Region Örebro County
University of Cambridge; Örebro University, Sweden; The Swedish Heart and Lung...

Recruiting

Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsE (ELIMINATE)

Cardiovascular Diseases | Inflammatory Response | Acute Myocardial Infarction

Sweden
Lisen Arnheim Dahlstrom
Merck Sharp & Dohme LLC

Completed

Effectiveness Study of Gardasil on Condyloma

Genital Warts | Condyloma

Sweden
Andreas Josefsson
Göteborg University; Umeå University; Sahlgrenska University Hospital, Sweden; Sundsvall... and other collaborators

Terminated

Enzalutamide Treatment in COVID-19 (COVIDENZA)

COVID-19 | Corona Virus Infection

Sweden
Umeå University
Värmland County Council, Sweden; Region Västerbotten; Örebro Läns Landsting; Region... and other collaborators

Recruiting

Immune Response to Vaccination Against Covid-19, a Follow up Study (CoVacc)

Covid19 | Vaccination; Infection

Sweden
Janssen Vaccines & Prevention B.V.

Completed

A Study of an Ad26.RSV. preF-based Vaccine in Adults Aged 18 to 59 Years, Including Adults at High Risk for Severe RSV Infection

Respiratory Syncytial Virus Infection Prevention

Germany, Spain, Belgium, Sweden, United States
Karolinska University Hospital
Uppsala University Hospital

Unknown

BK Viremia After Renal Transplantation

BK Virus Infection | Terminal Renal Failure

Sweden
Karolinska Institutet
Karolinska University Hospital

Completed

Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection

Glioblastoma Multiforme | Cytomegalovirus Infection

Sweden
Karolinska University Hospital
Karolinska Institutet

Withdrawn

Hepatitis B in Cystic Fibrosis and Latent Tuberculosis Respectively

Hepatitis B | Hepatitis A | Tuberculosis | Cystic Fibrosis

Sweden
University of Aarhus

Recruiting

The Impact of Camostat Mesilate on COVID-19 Infection (CamoCO-19)

Corona Virus Infection

Denmark, Sweden
Region Örebro County

Not yet recruiting

Primary TBE Vaccination for the Elderly

Vaccine | Tick-borne Encephalitis

Sweden
Karolinska Institutet
Karolinska University Hospital; The Swedish Research Council; Swedish Heart Lung... and other collaborators

Recruiting

Home Monitoring and Molecular Phenotyping of Patients With Post-COVID With Focus on Lung Involvement (HemCOV)

Long COVID

Sweden
Krister Tano

Completed

Glucose Oxidase as Treatment Against Common Cold

Common Cold

Sweden
Lund University
Coradil AB

Enrolling by invitation

The Effect of Probiotic and Zinc Supplementation on the Common Cold

Common Cold

Sweden
Göteborg University
The Swedish Research Council; Roche Pharma AG

Completed

Ribavirin Loading Dose or Priming and Concentration Targeting for HCV Genotype 1 (RibaC)

Hepatitis C

Sweden
Göteborg University
Sahlgrenska University Hospital, Sweden

Not yet recruiting

Discontinuation of Antiviral Therapy as a Strategy to Cure Hepatitis B (STOP-B)

Hepatitis B, Chronic

Sweden
Karolinska Institutet

Active, not recruiting

Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study

COVID-19

Sweden
Karolinska University Hospital

Completed

Resolving Inflammatory Storm in COVID-19 Patients by Omega-3 Polyunsaturated Fatty Acids -

COVID-19

Sweden
University Hospital, Linkoeping

Completed

COVID-19 in Home Healthcare

Covid19

Sweden
Karolinska Institutet
Karolinska University Hospital

Recruiting

Effects of Inspiratory Muscle Training After Covid-19 (ReCOV) (IMT-ReCov)

Covid-19 | Respiratory Complication | Post-Acute Covid-19 Syndrome

Sweden
Uppsala University
Healthcare Region Dalarna

Completed

Optimal Timing for Tracheostomy in Invasively Mechanically Ventilated COVID-19 Patients

COVID-19

Sweden
Pharma Holdings AS
CTC Clinical Trial Consultants AB

Recruiting

Study to Evaluate a Single Dose of LTX-109 in Subjects With COVID-19 (Coronavirus Disease 2019) Infection.

COVID-19

Sweden
NORDynamIC Study Group

Completed

Multicenter Study Evaluating 12 Versus 24 Weeks Therapy With Peginterferon and Ribavirin for Hepatitis C Virus (HCV) Genotype 2 or 3

Hepatitis C Virus

Sweden
Joakim Dillner
Karolinska University Hospital; Karolinska Institutet; Danderyd Hospital

Completed

Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19)

COVID-19

Sweden

Clinical Trials on Varicella Zoster Virus Infection in Sweden

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations